Compumed, Inc. operates in the Data processing and preparation sector. CompuMed, Inc. is a medical diagnostic product and service company focusing on the diagnosis, monitoring and management of diseases, such as cardiovascular disease and osteoporosis. The Company's primary business is the development and marketing of its osteoporosis testing technology, OsteoGram, and the computer interpretation of electrocardiograms (ECGs). It applies computing, medical imaging, telecommunications and networking technologies to provide medical professionals and patients with solutions for disease assessment and decision support. It has created an electronic telemedicine infrastructure to link clinical cardio-vascular data collected at the patient's point of care, such as 12-lead ECGs, provide computerized interpretation of the data and to transmit that data to cardiologists for over-read interpretations. The Company also develops imaging-based diagnostic systems for the detection of musculoskeletal diseases, such as Osteoporosis. In our complete report available for purchase the company is compared to: Biolife Solutions, Inc., Interleukin Genetics, Inc. and Omeros Corporation.